Discover and read the best of Twitter Threads about #GeneDrive
Most recents (4)
Opinion @washingtonpost by Kevin Esvelt @kesvelt @MIT inventor of #GeneDrive
"For 20 years, taxpayer-funded research programs have sought to identify or create pandemic-causing viruses, all with surprisingly little transparency."
h/t @TheSeeker268
washingtonpost.com/opinions/2021/…
"For 20 years, taxpayer-funded research programs have sought to identify or create pandemic-causing viruses, all with surprisingly little transparency."
h/t @TheSeeker268
washingtonpost.com/opinions/2021/…
@washingtonpost @kesvelt @MIT @TheSeeker268 "To discover many dangerous viruses, or learn to enhance weaker ones, is to share the blueprints for an arsenal of plagues. Good people advocate for such research.. [but] misuse could be worse than if any of those pathogens spilled over naturally."
@washingtonpost @kesvelt @MIT @TheSeeker268 "Instead, health and security agencies should work together, ideally with considerably more than the $65 billion requested by the White House, to build adequate defenses against future pandemics."
I'm deeply worried about future pandemics & nastier agents. Nature doesn’t try to kill us; humans will. This e-print details a universal early-warning system: a “Nucleic Acid Observatory” (#NAO).
arxiv.org/abs/2108.0267
1/20
arxiv.org/abs/2108.0267
1/20
All catastrophic bio-threats grow exponentially
All bio is made of nucleic acids
To detect all threats, deep sequence wastewater + rivers & look for exponentially growing fragments (k-mers)
arxiv.org/abs/2108.02678
#NAO
2/20
All bio is made of nucleic acids
To detect all threats, deep sequence wastewater + rivers & look for exponentially growing fragments (k-mers)
arxiv.org/abs/2108.02678
#NAO
2/20
Why a Nucleic Acid Observatory? @EricLander46: “to keep future viruses from becoming pandemics… (we need) early-warning systems to spot new biological threats anywhere in the world soon after they emerge” washingtonpost.com/opinions/2021/…
3/20
3/20
UK micro > small cap 🔬 snap shot
#Novacyt
Sales - £277m
Cash - £92m
COVID prods on sale - 10+
Market Cap - £565m
#Abingdon, #BBI, #Omega, #Avacta, #GeneDrive (#GDR) & #Yourgene
Sales - £28m > £30m (Yourgene £18>£20m)
Cash - 🤔
COVID prods on sale - 3🤔
Market Cap - £761m
#Novacyt
Sales - £277m
Cash - £92m
COVID prods on sale - 10+
Market Cap - £565m
#Abingdon, #BBI, #Omega, #Avacta, #GeneDrive (#GDR) & #Yourgene
Sales - £28m > £30m (Yourgene £18>£20m)
Cash - 🤔
COVID prods on sale - 3🤔
Market Cap - £761m
There's a margin of error to account for BBI accounts which aren't public, awaiting GeneDrive which reports 31/03, Avacta account were published 23/01 last yr.
Say £5m tops. Small fry when you consider imbalance of collective market capitalisations.
Say £5m tops. Small fry when you consider imbalance of collective market capitalisations.
I'll be live-tweeting the #NExTRAC #genedrive discussion here for as much of the meeting I can make.
The #NExTRAC #genedrives discussion is a test for its new framework for publicly deliberating emerging biotechnology, and evaluating whether and how such work should proceed. More info on the NExTRAC framework here osp.od.nih.gov/wp-content/upl…
The Gene Drives in Biomedical Research Working Group is charged with considering "whether existing biosafety guidance is adequate for contained lab research...and outline conditions (if any) under which NIH could consider supporting field release..."
